Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 368534, 8 pages
http://dx.doi.org/10.1155/2015/368534
Research Article

Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma

1Institute of Pathology, University Hospital of Cologne, Kerpenerstraße 62, 50924 Cologne, Germany
2Institute of General, Visceral and Minimal Invasive Surgery, Clinic Northwest, Steinbacher Hohl 2-26, 60488 Frankfurt am Main, Germany
3Institute of Pathology, Helios Clinic Wuppertal, University Clinic Witten-Herdecke, Heusnerstraße 40, 42283 Wuppertal, Germany

Received 24 October 2014; Accepted 3 March 2015

Academic Editor: Claudio Letizia

Copyright © 2015 Melanie von Brandenstein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Melanie von Brandenstein, Katharina Puetz, Monika Schlosser, et al., “Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma,” Disease Markers, vol. 2015, Article ID 368534, 8 pages, 2015. doi:10.1155/2015/368534